Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
5928976 | American Heart Journal | 2012 | 10 Pages |
Abstract
Among patients with HF receiving care in cardiology/multispecialty practices participating in a performance measure intervention, surviving, and having repeat LVEF assessment, close to one third of patients had a >10% improvement in LVEF at 24 months. These findings indicate that HF is not always a progressive disease and that differentiation of the heterogeneous HF phenotypes may set the stage for future research and therapeutic targets.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Jane E. MD, Gregg C. MD, Clyde W. MD, Nancy M. PhD, CCNS, CCRN, FAHA, Anne B. MD, J. Thomas MD, Patches Johnson PhD, Mark L. MD, Mandeep R. MD, Christopher M. MD, Dwight MD, Mary Norine MD, Mihai MD,